Rare Kidney Diseases Archives - NephU

+

Help Us Enhance Your NephU Experience

Help Us Enhance Your NephU Experience

User experience form

Email Address*(Required)

What is Your Specialty?*(Required)

Select all that apply (Select at least one)*

What are your goals for visiting NephU?(Required)

Learn about IgAN MOD and disease progression

Join the NephU community

Access additional IgAN resources

Select all that apply (Select at least one)*

How would you like to hear from us?(Required)

Biweekly Email Newsletters

Schedule a Meeting with a Medical Science Liaison

Learn About Upcoming Live/Virtual Events

Agree(Required)

By providing your name, email address, and other information, you are giving Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and companies working with OPDC permission to send you information from NephU. OPDC will not sell or transfer your name, address, or email address. You agree that should you use any material provided through NephU, you will attribute the source of that information to “NephU sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc.” For additional information, please read our Privacy Policy. By submitting your information, you agree to the terms provided above, and the terms provided in our Terms of Use and our Privacy Policy.

*Required Field

CAPTCHA

Steroids in IgA Nephropathy (TESTING Trials & STOP-IgAN)

Article April 1, 2025

The IgAN Literature Review program explores significant advancements in the management of IgA nephropathy through evidence-based discussions. This journal club fosters scientific exchange on selected publications, offering a unique opportunity… Read More

Incidence of Adult Primary Immunoglobulin A Nephropathy Among a Racially/Ethnically Diverse Population in the United States

Article April 1, 2025

The IgAN Literature Review program explores significant advancements in the management of IgA nephropathy through evidence-based discussions. This journal club fosters scientific exchange on selected publications, offering a unique opportunity… Read More

Long-Term Outcomes in IgA Nephropathy (RaDaR)

Article April 1, 2025

The IgAN Literature Review program explores significant advancements in the management of IgA nephropathy through evidence-based discussions. This journal club fosters scientific exchange on selected publications, offering a unique opportunity… Read More

IgA Nephropathy – From Pathogenesis to Current Management

Article April 22, 2024

This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide. During this presentation you will learn the clinical presentation, diagnosis, prognosis, and unmet treatment… Read More

Hypertension in Autosomal Dominant Polycystic Kidney Disease (ADPKD), Chronic Kidney Disease (CKD), & the General Population (GP)

Article February 6, 2024

This presentation will discuss the pathophysiology and management of HTN in patients with ADPKD, CKD, and the GP. Read More

Autosomal Dominant Polycystic Kidney Disease: The Role of Imaging in Diagnosis & Prognosis

Article August 25, 2023

Radiologists play a key role on the kidney care team in assisting in the diagnosis and prognosis of patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD). Measuring Total Kidney Volume… Read More

Mental Health In Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Article May 24, 2023

The goal of this presentation is to increase awareness surrounding the emotional and physical burden that ADPKD patients face. The presentation will also discuss the impact on patient’s caregivers as… Read More

Diagnostic Imaging & TKV: A Discussion on Breaking Barriers

Article February 5, 2023

In this presentation, the strengths and limitations of different imaging modalities nephrologists can use to obtain a TKV will be reviewed. The different methods radiologists can use to calculate TKV… Read More

Genetic Testing in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Article February 5, 2023

In this presentation, the complexities of genetic testing in ADPKD, recommendations on when genetic testing is appropriate and indicated, and the various types of molecular genetic tests available will be… Read More

Risk Factors for Rapid Disease Progression of ADPKD

Article January 12, 2023

In this presentation rapid disease progression of autosomal dominant polycystic kidney disease (ADPKD) will be defined. The risk factors that assist in determining if a patient is at risk of… Read More

NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the kidney health community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.

May 2025 US.CORP.D.25.00000

August 2024 US.CORP.X.24.00265

©2025 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved.